{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:19:05Z","timestamp":1792819145131,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015377","name":"Shanghai Key Laboratory of Molecular Imaging","doi-asserted-by":"publisher","award":["KFKT-2024-27"],"award-info":[{"award-number":["KFKT-2024-27"]}],"id":[{"id":"10.13039\/501100015377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015377","name":"Shanghai Key Laboratory of Molecular Imaging","doi-asserted-by":"publisher","award":["18DZ2260400"],"award-info":[{"award-number":["18DZ2260400"]}],"id":[{"id":"10.13039\/501100015377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0909000"],"award-info":[{"award-number":["2020YFA0909000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["ZH2018QNB20"],"award-info":[{"award-number":["ZH2018QNB20"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bioorg.2025.108445","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:38:34Z","timestamp":1744303114000},"page":"108445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and evaluation of 18F-labeled novel radiopharmaceuticals for PET imaging of fibroblast activation protein expressing tumors"],"prefix":"10.1016","volume":"160","author":[{"given":"Qingyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoumi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tukang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2025.108445_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108445_bb0010","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/cancers12092652","article-title":"Cancer-associated fibroblasts: versatile players in the tumor microenvironment","volume":"12","author":"Ganguly","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108445_bb0015","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","author":"Mori","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.bioorg.2025.108445_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2023.09.065","article-title":"Role of cancer-associated fibroblasts in colorectal cancer and their potential as therapeutic targets","volume":"681","author":"Yan","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108445_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140409","article-title":"Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications","volume":"1868","author":"\u0160imkov\u00e1","year":"2020","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108445_bb0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting Cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108445_bb0035","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/jm500031w","article-title":"Extended Structure\u2013Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)","volume":"57","author":"Jansen","year":"2014","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108445_bb0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective inhibitors of fibroblast activation protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108445_bb0045","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of Quinoline-based Theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108445_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/ph18020277","article-title":"Design, synthesis, and biological evaluation of a novel [(18)F]AlF-H3RESCA-FAPI radiotracer targeting fibroblast activation protein","volume":"18","author":"Zhang","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108445_bb0055","article-title":"Radiosynthesis and first preclinical evaluation of the novel (11)C-labeled FAP inhibitor (11)C-FAPI: a comparative study of (11)C-FAPIs and ((68)Ga)Ga-DOTA-FAPI-04 in a high-FAP-expression mouse model","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108445_bb0060","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00259-020-05095-0","article-title":"Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [(68)Ga]Ga-FAPI-04 PET\/CT versus MRI and [(18)F]-FDG PET\/CT","volume":"48","author":"Guo","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108445_bb0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.2020203275","article-title":"Comparison of (68)Ga-FAPI and (18)F-FDG uptake in gastric, duodenal, and colorectal cancers","volume":"298","author":"Pang","year":"2021","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108445_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2967\/jnumed.119.241232","article-title":"FAP: the next billion Dollar nuclear Theranostics target?","volume":"61","author":"Calais","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108445_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101852118","article-title":"An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications","volume":"118","author":"Millul","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108445_bb0080","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00259-021-05653-0","article-title":"Translational imaging of the fibroblast activation protein (FAP) using the new ligand [(68)Ga]Ga-OncoFAP-DOTAGA","volume":"49","author":"Backhaus","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108445_bb0085","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2967\/jnumed.108.060418","article-title":"A novel method of (18)F radiolabeling for PET","volume":"50","author":"McBride","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioorg.2025.108445_bb0090","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1021\/acs.molpharmaceut.4c01360","article-title":"Preclinical and first-in-human imaging of novel [(18)F]F-FAPI-FUSCC07 tracer: comparative prospective study with [(18)F]F-FAPI-42 and [(18)F]F-FAPI-74","volume":"22","author":"Bian","year":"2025","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108445_bb0095","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.apsb.2021.09.032","article-title":"Preclinical evaluation and pilot clinical study of [(18)F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts","volume":"12","author":"Hu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108445_bb0100","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s00259-024-06626-9","article-title":"Preclinical study and first-in-human imaging of [(18)F]FAP-2286, and comparison with 2-[(18)F]FDG PET\/CT in various cancer patients","volume":"51","author":"Liu","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108445_bb0105","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1007\/s00259-023-06282-5","article-title":"Noninvasive imaging of FAP expression using positron emission tomography: a comparative evaluation of a [(18)F]-labeled glycopeptide-containing FAPI with [(18)F]FAPI-42","volume":"50","author":"Huang","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"19","key":"10.1016\/j.bioorg.2025.108445_bb0110","doi-asserted-by":"crossref","first-page":"17785","DOI":"10.1021\/acs.jmedchem.4c01812","article-title":"(68)Ga\/(177)Lu-labeled Theranostic pair for targeting fibroblast activation protein with improved tumor uptake and retention","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108445_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106878","article-title":"Radiosynthesis, preclinical evaluation and pilot clinical PET imaging study of a (18)F-labeled tracer targeting fibroblast activation protein","volume":"141","author":"Fu","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108445_bb0120","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/ph15080958","article-title":"Automated Radiosynthesis, preliminary in vitro\/in vivo characterization of OncoFAP-based radiopharmaceuticals for Cancer imaging and therapy","volume":"15","author":"Bartoli","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108445_bb0125","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2967\/jnumed.113.121533","article-title":"A comparative study of radiolabeled Bombesin analogs for the PET imaging of prostate Cancer","volume":"54","author":"Liu","year":"2013","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108445_bb0130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1021\/acsptsci.3c00187","article-title":"Design, synthesis, and evaluation of (18)F-labeled tracers targeting fibroblast activation protein for brain imaging","volume":"6","author":"Yu","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"8015","key":"10.1016\/j.bioorg.2025.108445_bb0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","article-title":"Covalent targeted radioligands potentiate radionuclide therapy","volume":"630","author":"Cui","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108445_bb0140","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1021\/acs.jmedchem.5c00132","article-title":"(99m)Tc-labeled quinolone-based novel skeletal tracers for tumor visualization through fibroblast activation protein","volume":"68","author":"Luo","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108445_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115862","article-title":"Next generation fibroblast activation protein (FAP) targeting PET tracers - the tetrazine ligation allows an easy and convenient way to (18)F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines","volume":"262","author":"Poulie","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108445_bb0150","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s00259-021-05646-z","article-title":"[(18)F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [(68)Ga]Ga-FAPI-04","volume":"49","author":"Hu","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825003256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825003256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:58:13Z","timestamp":1777463893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825003256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"alternative-id":["S0045206825003256"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108445","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and evaluation of 18F-labeled novel radiopharmaceuticals for PET imaging of fibroblast activation protein expressing tumors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108445"}}